Log In
Print
BCIQ
Print
Print this Print this
 

CM-AT

  Manage Alerts
Collapse Summary General Information
Company Curemark LLC
DescriptionPowder formulation of an undisclosed enzyme that is released in the small intestine to aid in protein digestion
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentRegistration
Standard IndicationAutism
Indication DetailsTreat autism
Regulatory Designation

U.S. - Fast Track (Treat autism)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today